IL110585A0 - Tripeptides, their preparation and pharmaceutical compositions containing them - Google Patents

Tripeptides, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL110585A0
IL110585A0 IL11058594A IL11058594A IL110585A0 IL 110585 A0 IL110585 A0 IL 110585A0 IL 11058594 A IL11058594 A IL 11058594A IL 11058594 A IL11058594 A IL 11058594A IL 110585 A0 IL110585 A0 IL 110585A0
Authority
IL
Israel
Prior art keywords
tripeptides
pharmaceutical compositions
compositions containing
preparation
peptides
Prior art date
Application number
IL11058594A
Other languages
English (en)
Original Assignee
Immunobiology Res Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Res Inst Inc filed Critical Immunobiology Res Inst Inc
Publication of IL110585A0 publication Critical patent/IL110585A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL11058594A 1993-08-26 1994-08-08 Tripeptides, their preparation and pharmaceutical compositions containing them IL110585A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/112,413 US5639729A (en) 1993-08-26 1993-08-26 Tripeptides useful in immune and CNS therapy

Publications (1)

Publication Number Publication Date
IL110585A0 true IL110585A0 (en) 1994-11-11

Family

ID=22343770

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11058594A IL110585A0 (en) 1993-08-26 1994-08-08 Tripeptides, their preparation and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US5639729A (sv)
EP (1) EP0723454B1 (sv)
JP (1) JPH09502175A (sv)
KR (1) KR960703612A (sv)
CN (1) CN1133563A (sv)
AT (1) ATE207757T1 (sv)
BR (1) BR9407357A (sv)
CA (1) CA2169072A1 (sv)
CZ (1) CZ55496A3 (sv)
DE (1) DE69428909D1 (sv)
FI (1) FI960839A0 (sv)
HU (1) HUT73777A (sv)
IL (1) IL110585A0 (sv)
NO (1) NO960710L (sv)
PL (1) PL313257A1 (sv)
WO (1) WO1995005841A1 (sv)
ZA (1) ZA946008B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びFischer比低下の少なくとも1つの軽減剤
ATE435852T1 (de) 2001-05-24 2009-07-15 Neuren Pharmaceuticals Ltd Gpe-analoga und peptidomimetika
US7714020B2 (en) * 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
US7605177B2 (en) * 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
US20070004641A1 (en) * 2001-05-24 2007-01-04 Neuren Pharmaceuticals Limited Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamate
SG187271A1 (en) * 2011-07-07 2013-02-28 Agency Science Tech & Res Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutic

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs
US5028592A (en) * 1986-08-08 1991-07-02 Lipton James M Antipyretic and anti-inflammatory peptides
IT1216908B (it) * 1987-03-19 1990-03-14 Eniricerche Spa Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
IT1222437B (it) * 1987-08-04 1990-09-05 Ellem Ind Farmaceutica Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
HU201095B (en) * 1988-06-14 1990-09-28 Richter Gedeon Vegyeszet New peptides inhibiting the activity of the immune system and pharmaceutical compositions comprising same, as well as process for producing these peptides and compositions
KR900701298A (ko) * 1988-09-30 1990-12-01 원본미기재 T-세포 억제작용을 보유한 펩티드
DD296084A5 (de) * 1989-07-27 1991-11-21 Adw Verfahren zur herstellung von humanen spleninderivaten

Also Published As

Publication number Publication date
AU7868194A (en) 1995-03-21
HUT73777A (en) 1996-09-30
FI960839A (sv) 1996-02-23
CZ55496A3 (en) 1996-08-14
NO960710D0 (no) 1996-02-22
US5639729A (en) 1997-06-17
JPH09502175A (ja) 1997-03-04
ATE207757T1 (de) 2001-11-15
CN1133563A (zh) 1996-10-16
DE69428909D1 (de) 2001-12-06
NO960710L (no) 1996-02-22
EP0723454A4 (en) 1998-07-29
ZA946008B (en) 1995-03-29
HU9600432D0 (en) 1996-04-29
FI960839A0 (sv) 1996-02-23
KR960703612A (ko) 1996-08-31
CA2169072A1 (en) 1995-03-02
EP0723454A1 (en) 1996-07-31
PL313257A1 (en) 1996-06-24
BR9407357A (pt) 1996-10-29
EP0723454B1 (en) 2001-10-31
WO1995005841A1 (en) 1995-03-02
AU682898B2 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
AU693747B2 (en) Imidazo(4,5-c)pyridin-4-amines
HU9201712D0 (en) A mammalian cytokine, il-11
ES8900017A1 (es) Procedimiento para la preparacion de dipeptidos de n,n-dialquil-guanidino.
CA2285430A1 (en) Calcium phosphate microcarriers and microspheres
IL110754A0 (en) Cell compositions preparation and therapeutic uses
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
IL110284A0 (en) Viral vectors and their use in gene therapy
UA43348C2 (uk) Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад
DE3586697D1 (en) Aktive thymopentin-analoga.
AU1179795A (en) Improved immunogenic compositions against human gastrin 17
ES8607732A1 (es) Procedimiento para producir un preparado implantable de un peptido regulador, uno de sus analogos o una de sus sales fisiologicamente compatibles.
EP0720482A4 (en) PROSAPOSIN AND CYTOKIN-DERIVED PEPTIDES AS THERAPEUTIC ACTIVE SUBSTANCES
AU1750097A (en) Highly concentrated, lyophilized, and liquid factor ix formulations
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
IL107674A0 (en) Multifunctional neurotrophic factors
IL110585A0 (en) Tripeptides, their preparation and pharmaceutical compositions containing them
AU6877587A (en) Expellants of phytopathogenic microbes
IL102065A0 (en) Peptides useful in regulating the immune and nervous systems,their preparation and pharmaceutical compositions containing them
MY113432A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and medicaments containing them
NZ326769A (en) High-content famciclovir tablets
AU1275095A (en) Antiviral composition of viral protein trans-dominant variants
TW346397B (en) Cell cycle controlling compositions and methods of using same
RU93005016A (ru) Иммунорегуляторные и нейрорегуляторные пентапептиды, фармацевтические композиции на их основе, способ получения пентапептидов, способ лечения
MX9705959A (es) Formulaciones para il-12.
MX9802380A (es) Formas cortas de quimiocina beta-8.